Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the white blood cells, specifically a type called lymphocytes. ALL is the most common type of childhood cancer, but it can also occur in adults. It is characterized by the rapid and uncontrolled growth of abnormal white blood cells in the bone marrow. Research in the area of acute lymphoblastic leukemia focuses on understanding the underlying causes of the disease, developing more effective treatments, improving survival rates, and reducing side effects of therapy. This research may include studying genetic mutations that contribute to the development of ALL, identifying new targeted therapies, and exploring ways to improve the immune system's ability to fight cancer cells. Overall, research in acute lymphoblastic leukemia aims to improve outcomes for patients by advancing our understanding of the disease and developing better treatment options.